Unlocking the potential of engineered immune cell therapy for solid tumors
Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.
Saved in:
Main Authors: | Víctor Albarrán-Fernández, Laura Angelats, Julio Delgado, Alena Gros, Álvaro Urbano-Ispizua, Sònia Guedan, Aleix Prat |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-025-56527-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study
by: Javier García-Corbacho, et al.
Published: (2025-02-01) -
Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets
by: Sanya Arshad, et al.
Published: (2025-01-01) -
Unlocking torts /
by: Turner, Chris
Published: (2020) -
Unlocking evidence /
by: Singh, Charanjit, et al.
Published: (2016) -
Interaction among Cells of Bone, Immune System, and Solid Tumors Leads to Bone Metastases
by: Ilaria Roato
Published: (2013-01-01)